Navigation Links
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
Date:1/30/2013

asis, the Company repurchased 393,100 shares in the open market at an average cost of $40.24 during the third quarter.  On a year-to-date basis, the Company has repurchased 541,700 shares at an average price of $39.07, returning $21.2 million to shareholders.  The Board of Directors previously approved the repurchase of up to $50 million of shares in the open market during fiscal 2013.

Conference CallHaemonetics will host a webcast to discuss the first quarter results on Wednesday, January 30, 2013 at 8:00 am Eastern time.  Interested parties can participate at: http://phoenix.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4888434.

About HaemoneticsHaemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

Forward Looking StatementsThis release contains forward-looking statements that involve risks and uncertainties, including the effects of disruption from the acquisition of the Pall Transfusion Medicine business making it more difficult to maintain relationships with employees, customers, vendors and other business partners, unexpected expenses incurred to integrate the Pall T
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
2. Haemonetics Completes Acquisition of Palls Transfusion Medicine Business
3. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
4. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
5. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
6. Lilly Reports Fourth-Quarter and Full-Year 2012 Results, Revises 2013 EPS Guidance
7. Danaher Reports Record Fourth Quarter 2012 Results
8. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
9. Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
10. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
11. Cepheid Reports Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... LAVAL, Quebec , July 24, 2014 /PRNewswire/ ... VRX ) (TSX:VRX) announced today that it ... des marches financiers ("AMF") regarding Allergan, Inc.,s (NYSE: ... investors and to negatively influence the market price ... false and misleading statements regarding Valeant,s business despite ...
(Date:7/24/2014)... , Revenues from continuing operations of ... diluted EPS from continuing operations of $1.08, up 1.9% versus  ... of $0.92, 7% below prior year , Cash from ... , Full year 2014 revenues now expected to be up ... , Full year 2014 adjusted diluted EPS range narrowed to  ...
(Date:7/24/2014)... DIEGO , July 24, 2014   ... announced today a co-promotion agreement with Illumina to ... genome sequence data for precision medicine and clinical ... pharmaceutical companies, through Illumina,s sales force, a solution ... platform for data analytics and storage, and Cypher ...
Breaking Medicine Technology:Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 2Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 3Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 4Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 5Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements 6Quest Diagnostics Reports Second Quarter 2014 Financial Results 2Quest Diagnostics Reports Second Quarter 2014 Financial Results 3Quest Diagnostics Reports Second Quarter 2014 Financial Results 4Quest Diagnostics Reports Second Quarter 2014 Financial Results 5Quest Diagnostics Reports Second Quarter 2014 Financial Results 6Quest Diagnostics Reports Second Quarter 2014 Financial Results 7Quest Diagnostics Reports Second Quarter 2014 Financial Results 8Quest Diagnostics Reports Second Quarter 2014 Financial Results 9Quest Diagnostics Reports Second Quarter 2014 Financial Results 10Quest Diagnostics Reports Second Quarter 2014 Financial Results 11Quest Diagnostics Reports Second Quarter 2014 Financial Results 12Quest Diagnostics Reports Second Quarter 2014 Financial Results 13Quest Diagnostics Reports Second Quarter 2014 Financial Results 14Quest Diagnostics Reports Second Quarter 2014 Financial Results 15Quest Diagnostics Reports Second Quarter 2014 Financial Results 16Quest Diagnostics Reports Second Quarter 2014 Financial Results 17Quest Diagnostics Reports Second Quarter 2014 Financial Results 18Quest Diagnostics Reports Second Quarter 2014 Financial Results 19Quest Diagnostics Reports Second Quarter 2014 Financial Results 20Quest Diagnostics Reports Second Quarter 2014 Financial Results 21Quest Diagnostics Reports Second Quarter 2014 Financial Results 22Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 2Cypher Genomics and Illumina Enter Agreement to Facilitate Genomic Biomarker Discovery 3
... RIVER, Mass., May 9, 2012  Millstone Medical Outsourcing ... as Vice President of Quality Systems.  As a ... she will be responsible for managing the quality ... all quality associates, and working closely with customers ...
... Md., May 8, 2012 /PRNewswire-iReach/ -- Reimbursement ... device development and commercialization plan. For new product launches ... and quality of life benefits versus comparators to payers, ... ISPOR 2012 highlight these trends:  IMPACT OF ...
Cached Medicine Technology:Millstone Medical Outsourcing Hires New Vice President Quality 2Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies 2
(Date:7/24/2014)... Dr. Peter Oettgen, a member of the ... Boston, is the new Deputy Editor of Cardiology for ... experience in the field to the evidence-based, clinical reference ... Oettgen received his medical degree from the University of ... Tufts New England Medical Center. He is the Director ...
(Date:7/24/2014)... The European Omega 3 & Structured Lipids Market ... market in Europe with analysis and forecast of revenue. The ... 2012 to $989.91 million by 2018, at a CAGR of ... of the European omega 3 & structured lipids market report, ... also provides a glimpse of the segmentation of the European ...
(Date:7/24/2014)... Bethesda, MD (PRWEB) July 24, 2014 ... cells circulating in a patient’s blood has been achieved ... team at Massachusetts General Hospital. This is an important ... new approach to selecting the best treatment for each ... said Dr. Haber. “They often acquire new genetic features ...
(Date:7/24/2014)... The European air and missile defense radar market ... expected to register a CAGR of 8.06%, to reach $2.07 ... are the major spenders in the region with a number ... program and multinational (MEADS) program, which has been co-developed by ... of the Europe air and missile defense radar market report, ...
(Date:7/24/2014)... 24 July 2014. LSE Health and the European ... Cardiology (ESC) are pleased to announce the launch ... working in the field of cardiovascular sciences. , ... in Cardiovascular Sciences aims to equip cardiovascular specialists ... skills required to take on advisory, management or ...
Breaking Medicine News(10 mins):Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 2Health News:DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology 3Health News:Europe Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $989.91 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $989.91 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Omega 3 & Structured Lipids (Nutraceuticals) Market is Expected to Reach $989.91 Million in 2018 - New Report by MicroMarket Monitor 4Health News:New Blood Test Advances Individualized Cancer Therapy and Cuts Down on Need for Painful Biopsies 2Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 2Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 3Health News:Europe Air and Missile Defense Radar Market is Expected to Reach $2.07 billion in 2020 - New Report by MicroMarket Monitor 4Health News:LSE and ESC announce the launch of a new executive-style MSc 2
... in-patient rehabilitation are more likely to land back in ... poorly, show signs of depression and lack social support ... Branch (UTMB) at Galveston. Hospital readmission for older adults ... billion annually. , Among the first of such ...
... , FRIDAY, April 6 (HealthDay News) -- Children ... late may experience more severe symptoms than kids with autism ... These children also may be more likely to inflict ... more severe remain unknown, the study suggested it may have ...
... chemotherapy try to kill tumors by causing oxidative stress in ... protects cancer and other cells from these stresses could one ... them more susceptible to treatment. In the March 23 ... led by USC Professor Kelvin J. A. Davies demonstrated that ...
... FRIDAY, April 6 (HealthDay News) -- Patients with ... exposed to significant levels of radiation from diagnostic imaging ... data from 2,590 patients with gastrointestinal disorders between ... them had undergone diagnostic imaging tests such as computed ...
... News) -- Overuse injuries account for more than one-quarter of ... has found. Women -- especially those who played field ... of the overuse injuries (62 percent). For this study, ... collegiate athletes participating in 16 team sports at the University ...
... ,Airport security screening has increased substantially during the past ... According to the American Academy of Orthopaedic Surgeons ... were performed in the United States. A new ... Checkpoints: How Has Heightened Security Affected Patients," appearing ...
Cached Medicine News:Health News:Predictors identified for rehospitalization among post-acute stroke patients 2Health News:Predictors identified for rehospitalization among post-acute stroke patients 3Health News:Pregnancy Length May Influence Severity of Autism 2Health News:Scientists identify major source of cells' defense against oxidative stress 2Health News:Diagnostic Scans Tied to Radiation Risk for Gastro Patients 2Health News:Overuse Injuries Common Among Female College Athletes 2Health News:Clinical news alert from the American Academy of Orthopaedic Surgeons 2
Inquire...
The new Gemini EM microplate spectrofluorometer builds on the successful Gemini platform. This next generation reader incorporates all of the high performance features of the Gemini XS with new capab...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
... from Berthold Technologies, has been designed ... measurement modes to support academic and ... ratio measurements plus top and bottom ... for any researcher using fluorescence in ...
Medicine Products: